Agrow is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

DuPont/BioLeap agchem discovery deal

DuPont has entered into a research collaboration with US drug discovery company BioLeap (Pennington, New Jersey) to use BioLeap’s molecular design technology to discover new crop protection compounds. BioLeap will use its proprietary technology in computational fragment-based design to identify compounds aimed at biological targets of interest to DuPont. The companies will jointly select compounds for synthesis and further evaluation by DuPont. The terms of the deal, including discovery milestones, have not been disclosed. BioLeap formed a similar collaboration with Syngenta earlier this year ( Agrow No 614, p 3).

Advertisement

Topics

What to read next

Advertisement
UsernamePublicRestriction

Register

AG005431

Ask The Analyst

Please fill in the form below to send over your enquiry or check the Ask The Analyst Page to find out more about the service

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel